We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NREF
2126
NexPoint Real Estate Finance
NREF
$316M
| $23.4K | ﹤0.01% |
1,700
| – | – |
|
2127
Larimar Therapeutics
LRMR
$416M
| $22.8K | ﹤0.01% |
7,900
| – | – |
|
2128
Ouster
OUST
$2.29B
| $21.8K | ﹤0.01% |
+900
| New | +$10.9K |
|
2129
New Oriental
EDU
$7.84B
| $21.7K | ﹤0.01% |
403
| – | – |
|
|
ACR
2130
ACRES Commercial Realty
ACR
$126M
| $21.5K | ﹤0.01% |
+1,200
| New | +$22K |
|
|
RPT
2131
Rithm Property Trust
RPT
$90.5M
| $21.3K | ﹤0.01% |
+1,317
| New | +$21.4K |
|
|
NMAX
2132
Newsmax Inc
NMAX
$969M
| $21.2K | ﹤0.01% |
+1,400
| New | +$36.7K |
|
2133
Bank of Hawaii
BOH
$3.33B
| $20.3K | ﹤0.01% |
300
-300
| -50% | -$19.9K |
|
2134
ProFrac Holding
ACDC
$771M
| $20.2K | ﹤0.01% |
+2,600
| New | +$17K |
|
|
UPB
2135
Upstream Bio Inc
UPB
$349M
| $19.8K | ﹤0.01% |
1,800
-1,400
| -44% | -$12.9K |
|
2136
Genius Sports
GENI
$1.73B
| $19.8K | ﹤0.01% |
+1,900
| New | +$19K |
|
|
RAPP
2137
Rapport Therapeutics
RAPP
$1.95B
| $19.3K | ﹤0.01% |
1,700
| – | – |
|
|
LFT
2138
Lument Finance Trust
LFT
$41.9M
| $19K | ﹤0.01% |
+8,600
| New | +$21.7K |
|
2139
Arrowhead Research
ARWR
$12.1B
| $19K | ﹤0.01% |
+1,200
| New | +$17.2K |
|
2140
Perspective Therapeutics
CATX
$332M
| $18.2K | ﹤0.01% |
5,300
| – | – |
|
2141
WaFd
WAFD
$2.72B
| $17.6K | ﹤0.01% |
+600
| New | +$17K |
|
2142
Seaboard Corp
SEB
$4.52B
| $17.2K | ﹤0.01% |
+6
| New | +$15.8K |
|
2143
TFS Financial
TFSL
$5.1B
| $16.2K | ﹤0.01% |
+1,252
| New | +$16.1K |
|
2144
Capri Holdings
CPRI
$1.77B
| $15.9K | ﹤0.01% |
+900
| New | +$14.8K |
|
2145
UWM Holdings
UWMC
$621M
| $15.5K | ﹤0.01% |
+3,750
| New | +$16.5K |
|
2146
FVCBankcorp
FVCB
$324M
| $15.3K | ﹤0.01% |
1,300
| – | – |
|
|
AARD
2147
Aardvark Therapeutics
AARD
$138M
| $14.9K | ﹤0.01% |
+1,100
| New | +$11.3K |
|
|
AFCG
2148
AFC Gamma
AFCG
$58.6M
| $14.8K | ﹤0.01% |
3,300
| – | – |
|
2149
US Gold Corp
USAU
$220M
| $14.6K | ﹤0.01% |
+1,200
| New | +$13.2K |
|
|
SFD
2150
Smithfield Foods
SFD
$10.3B
| $14.4K | ﹤0.01% |
+612
| New | +$13.5K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.